Ampicillin

Penbritin-S

125MG BASE/VIAL, 1GM BASE/VIAL, 250MG BASE/VIAL injectableVereinigte StaatenNicht im HandelZugelassen am 29. Dez. 1966

In anderen Ländern

Dieselben Wirkstoffe in anderen Registern, dieselbe Marke zuerst.

Penbritin-1000 PWS 1000MG/VialKanada · 1 G / VIAL · Powder For Solution · Wyeth-Ayerst Canada INC.Gleiche Marke
Penbritin-125 PWS 125MG/VialKanada · 125 MG / VIAL · Powder For Solution · Wyeth-Ayerst Canada INC.Gleiche Marke
Penbritin-250 PWS IM/IV 250MG/VialKanada · 250 MG / VIAL · Powder For Solution · Wyeth-Ayerst Canada INC.Gleiche Marke
Penbritin Vial 250 MGSaudi-Arabien · Smiithkline BeechamGleiche Marke
Penbritin Injection 100MGTaiwan · 注射劑 · 友信行股份有限公司Gleiche Marke
STANDACILLIN FOR INJECTION 0.5 g/vialSingapur · 500 mg/vial · injection, powder, for solution · Sandoz Singapore Pte. LTD.Gleiche Stärke und Darreichungsform

Packung	Code	Status
AMPICILLIN SODIUM EQ 4GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	NDA050072-006	Discontinued
AMPICILLIN SODIUM EQ 1GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	NDA050072-004	Discontinued
AMPICILLIN SODIUM EQ 250MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	NDA050072-002	Discontinued
AMPICILLIN SODIUM EQ 2GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	NDA050072-005	Discontinued
AMPICILLIN SODIUM EQ 500MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	NDA050072-003	Discontinued
AMPICILLIN SODIUM EQ 125MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	NDA050072-001	Discontinued